MedPath

Yonsei University

Yonsei University logo
🇰🇷South Korea
Ownership
Private
Established
1885-01-01
Employees
5K
Market Cap
-
Website
http://www.yonsei.ac.kr

Impact of IntraVascular UltraSound Guidance on the Outcomes of Xience Prime Stents in Long Lesions (IVUS-XPL Study): Retrospective and Prospective Follow-up Study

Recruiting
Conditions
Myocardial Ischemia(Implanted Drug-eluting Stents Because of Ischemic Heart Disease(Stable Angina, Acute Coronary Syndrome))
First Posted Date
2019-03-07
Last Posted Date
2020-10-14
Lead Sponsor
Yonsei University
Target Recruit Count
1400
Registration Number
NCT03866486
Locations
🇰🇷

Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of

The Comparison of Changes of QTc, Tp-e Interval, and Tp-e/QT Ratio, Tp-e/QTc Ratio on the ECG During Living Donor Liver Transplantation Under Desflurane and Total Intravenous Anesthesia -Randomized Controlled Trial

Not Applicable
Completed
Conditions
Liver Cirrhosis(Who Will Undergo Planed Liver Transplantation)
Interventions
Drug: inhalation (desflurane) group
Drug: total intravenous (propofol) anesthesia
First Posted Date
2019-03-06
Last Posted Date
2021-10-15
Lead Sponsor
Yonsei University
Target Recruit Count
120
Registration Number
NCT03864276
Locations
🇰🇷

Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea, Republic of

Efficacy and Safety of Extract of Gelidium Elegans

Not Applicable
Completed
Conditions
Obesity
Interventions
Dietary Supplement: Exract of Gelidium elegans
Dietary Supplement: Placebo
First Posted Date
2019-02-15
Last Posted Date
2019-02-15
Lead Sponsor
Yonsei University
Target Recruit Count
94
Registration Number
NCT03842774
Locations
🇰🇷

Department of Family Medicine, Severance Hospital, College of Medicine, Yonsei University, Seoul, Korea, Republic of

Effects of a Nurse-delivered Cognitive Behaviour Therapy on Adherence and Depressive Symptoms in HIV Infected Persons of South Korea

Not Applicable
Conditions
HIV Infections
Interventions
Behavioral: Cognitive Behavioral Therapy
First Posted Date
2019-01-30
Last Posted Date
2019-01-30
Lead Sponsor
Yonsei University
Target Recruit Count
10
Registration Number
NCT03823261
Locations
🇰🇷

Division of Infectious Diseases, Department of Internal Medicine, Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of

Preoperative Chemoradiotherapy for Locally Advanced Resectable Gastric Adenocarcinoma

Phase 2
Completed
Conditions
Gastric Adenocarcinoma
Interventions
Radiation: radiation
First Posted Date
2019-01-24
Last Posted Date
2024-12-27
Lead Sponsor
Yonsei University
Target Recruit Count
102
Registration Number
NCT03814759
Locations
🇰🇷

Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of

A Study of Eribulin With Gemcitabine in Patients With Advanced Liposarcoma or Leiomyosarcoma

Phase 2
Completed
Conditions
Sarcoma
Interventions
First Posted Date
2019-01-22
Last Posted Date
2022-06-16
Lead Sponsor
Yonsei University
Target Recruit Count
37
Registration Number
NCT03810976
Locations
🇰🇷

Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of

A Study of Pemetrexed Plus Cisplatin in Patients With Refractory Soft Tissue Sarcoma

Phase 2
Completed
Conditions
Sarcoma
Interventions
First Posted Date
2019-01-18
Last Posted Date
2024-12-18
Lead Sponsor
Yonsei University
Target Recruit Count
37
Registration Number
NCT03809637
Locations
🇰🇷

Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of

A Study of Durvalumab in Combination With Doxorubicin for Advanced Soft Tissue Sarcoma

Phase 1
Conditions
Sarcoma
Interventions
Drug: Durvalumab+doxorubicin cobination
First Posted Date
2019-01-14
Last Posted Date
2022-06-01
Lead Sponsor
Yonsei University
Target Recruit Count
44
Registration Number
NCT03802071
Locations
🇰🇷

Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of

A Study of Pazopanib and Durvalumab for Metastatic Soft Tissue Sarcoma

Phase 2
Completed
Conditions
Sarcoma
Interventions
First Posted Date
2019-01-09
Last Posted Date
2023-06-12
Lead Sponsor
Yonsei University
Target Recruit Count
46
Registration Number
NCT03798106
Locations
🇰🇷

Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of

Ticagrelor Monotherapy in PAtients Treated With New-generation Drug-eluting Stents for Acute Coronary Syndrome; T-PASS Trial

Not Applicable
Recruiting
Conditions
Coronary Artery Disease, Acute Coronary Syndrome
Interventions
First Posted Date
2019-01-09
Last Posted Date
2023-03-07
Lead Sponsor
Yonsei University
Target Recruit Count
2850
Registration Number
NCT03797651
Locations
🇰🇷

Yonsei Cardiovascular Center and Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath